Eversept Partners, LP F Star Therapeutics, Inc. Transaction History

Eversept Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.77 - $5.36 $138,314 - $267,640	-49,933 Closed	0 $0
Q3 2021 Nov 08, 2023	SELL	$5.2 - $8.42 $260,348 - $421,564	-50,067 Reduced 50.07%	49,933 $365,000
Q3 2021 Nov 15, 2021	SELL	$5.2 - $8.42 $260,348 - $421,564	-50,067 Reduced 50.07%	49,933 $366,000
Q2 2021 Nov 08, 2023	BUY	$6.57 - $10.71 $657,000 - $1.07 Million	100,000 New	100,000 $859,000
Q2 2021 Aug 16, 2021	BUY	$6.57 - $10.71 $657,000 - $1.07 Million	100,000 New	100,000 $859,000

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.